QQ客服 官方微博 反馈留言

	In silico identification of novel kinase inhibitors targeting wildtype and T315I mutant ABL1 from FDA-approved drugs
	Jinku Bao; Huailong Xu; Zijie Wang; Xiaomeng Liang; Xin Li; Zheng Shi; Nan Zhou
刊名	Molecular BioSystems
	2014
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1838676
专题	四川大学
作者单位	1.Guizhou Normal Univ, Sch Life Sci, Guiyang 550001, Peoples R China 2.Sichuan Univ, Key Lab Bioresources, Minist Educ, Chengdu 610064, Peoples R China 3.Sichuan Univ, Sch Life Sci, Minist Educ, Chengdu 610064, Peoples R China
推荐引用方式 GB/T 7714	Jinku Bao,Huailong Xu,Zijie Wang,et al. In silico identification of novel kinase inhibitors targeting wildtype and T315I mutant ABL1 from FDA-approved drugs[J]. Molecular BioSystems,2014.
APA	Jinku Bao.,Huailong Xu.,Zijie Wang.,Xiaomeng Liang.,Xin Li.,...&Nan Zhou.(2014).In silico identification of novel kinase inhibitors targeting wildtype and T315I mutant ABL1 from FDA-approved drugs.Molecular BioSystems.
MLA	Jinku Bao,et al."In silico identification of novel kinase inhibitors targeting wildtype and T315I mutant ABL1 from FDA-approved drugs".Molecular BioSystems (2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。